FDA's Oncology Center of Excellence, its new face for oncology drug development, is now officially on the agency organization chart.
OCE is on par with Center for Drug Evaluation and Research (CDER), as well as the biologics and device centers, under a new organizational structure. FDA announced the change in a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?